核子医学设备市场（按技术、产品类型、应用和最终用户划分）—2025-2030 年全球预测

预计核医设备市场规模在 2024 年将达到 42.3 亿美元，在 2025 年将成长至 45.1 亿美元，在 2030 年将达到 62.7 亿美元，复合年增长率为 6.76%。

主要市场统计数据
基准年2024年	42.3亿美元
预计2025年	45.1亿美元
预计2030年	62.7亿美元
复合年增长率（%）	6.76%

对影响全球医疗保健诊断和治疗创新的核子医学设备进行全面调查

过去十年，核子医学设备已成为日益个人化诊断和治疗途径的关键，彻底改变了临床医生检测和治疗复杂疾病的方式。随着医疗服务提供者努力提高准确性和患者预后，先进的成像模式和靶向放射性药物输送系统已成为医学创新的前沿。这项转变的推动力源自于检测器灵敏度、影像重建演算法以及影像和治疗能力融合的突破性进展。因此，核子医学如今在多学科治疗模式中占据着举足轻重的地位，为在分子层面上洞察生理过程提供了前所未有的视角。

透过人工智慧分析、治疗诊断学和精密成像的集成，阐明推动下一代核医学设备的模式转移

核子医学设备格局正在被各种趋势再形成，这些趋势正在重新定义临床工作流程和研究前沿。其中最重要的是将人工智慧和机器学习融入影像撷取和解读。透过自动化影像分割并以前所未有的精度量化示踪剂摄取，这些演算法正在简化决策流程并减轻放射科医生的工作量。同时，分子影像剂兼作治疗工具的诊疗方法的普及，正在为个人化医疗开闢新的维度。标靶放射性核治疗现在可以透过诊断反馈迴路进行即时指导，从而确保更高的疗效并最大限度地减少脱靶效应。

评估美国关税对核子医学设备供应链的连锁反应：製造成本与全球合作

2025年，美国新颁布的关税政策对核医设备生态系统产生了多方面的连锁反应。进口检测器、CT模组和专用零件的关税上调，迫使製造商重新评估其全球供应链架构。为此，领先的设备製造商正在多元化筹资策略，并加快对本地组装和零件製造的投资。虽然这些调整旨在抵消不断上升的进口成本，但鑑于放射性物质和诊断成像设备所适用的严格安全标准，它们也带来了品管和法规合规的复杂性。

从核医设备市场综合技术产品类型应用和最终用户细分中获得的策略见解

从技术采用、产品类型差异化、临床应用和最终用户专业化角度获得的洞察揭示了塑造当今核医学市场的复杂因素。包括 PET/CT 和 SPECT/CT 在内的混合影像平台的演变，凸显了向无缝整合功能和解剖数据并满足肿瘤分期和神经系统评估严格要求的系统转变。同时，诊断和治疗设备与放射性药物之间的界限凸显了双轨策略：一方面侧重于影像采集和解读，另一方面侧重于靶向放射性配体的治疗递送。

了解美洲、欧洲、中东、非洲和亚太地区的区域动态，以揭示核子医学影像的成长动力和采用模式

美洲、中东和非洲以及亚太地区的区域动态正在推动不同的采用率和创新轨迹。在美洲，完善的医疗保健基础设施和雄厚的研究资金持续推动先进 PET/CT 和诊疗平台的早期应用。北美医疗机构正在大规模采用整合成像模式，而拉丁美洲市场对可携式SPECT/CT 解决方案的兴趣日益浓厚，旨在将诊断服务扩展到都市区。

了解全球核子医学设备主要参与企业的竞争领导力和协作创新策略

核子医学设备领域的主要参与企业正在采取多管齐下的策略，以保持竞争优势并促进技术应用。大型跨国公司透过有针对性的收购和策略研究合作，不断扩展产品系列，将先进的检测器技术和人工智慧软体融入其现有平台。同时，区域性中型公司则专注于经济高效的模组化系统和迎合新兴市场的在地服务模式，开拓专业化的利基市场。

产业领导者制定可行的蓝图，以优化技术投资、建立策略伙伴关係并改善患者治疗效果

为了抓住技术融合和监管变革带来的机会，产业领导者应优先对用于诊断成像和治疗应用的模组化、可扩展平台进行策略性投资。采用灵活的製造框架有助于加速下一代检测器和放射性药物的部署，同时减少供应链中断。建立由监管事务、临床专家和资料科学家组成的跨职能团队，可以进一步简化产品核可流程，并提高市场应对力。

严格的混合方法的详细信息，该方法将一手资料和二手资料研究与先进的分析技术相结合，以确保数据的完整性和可靠性

研究采用混合方法框架，将与临床医生、影像专业人员和采购主管进行的广泛一手资料研究与严谨的二手资料研究相结合，包括同行评审期刊、监管资料库和专利申请。一手资料提供了对临床工作流程、采购标准和新兴需求的定性洞察，而二手资料则提供了背景检验和趋势分析。这些输入经过三角检验，以协调不同的观点，随后进行交叉检验研讨会，以完善关键假设并确保研究的稳健性。

将关键发现综合成前瞻性的观点，引导相关人员了解核医新兴趋势的机会与策略重要性

这份全面的评估揭示了决定核医设备未来发展的关键技术创新、监管因素和竞争动态。从混合影像系统和人工智慧主导的分析技术，到诊疗范式的兴起，相关人员将有机会释放巨大的临床和营运价值。关税驱动的供应链调整和区域差异化进一步凸显了敏捷策略规划和稳健伙伴关係生态系统的必要性。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 融合人工智慧和机器学习，提升PET扫描器影像重建的准确性和速度
• 开发无迴旋加速器放射性同位素生产，以分散社区医疗机构对 PET 示踪剂的获取
• 固体检测器的进步将提高下一代 SPECT 系统的飞行时间分辨率
• 肿瘤靶向放射性核素治疗与诊断影像结合的诊疗设备的出现
• 实施数位双胞胎模拟以优化核子医学设备的工作流程和维护计划
• 整合云端基础的资料管理，用于多模态核成像研究，实现即时远端解释
• 小巧、可携式的伽马摄影机有助于紧急心肌灌注成像
• 引入具有超高场强磁体的混合 PET/MRI 系统可改善脑部影像中的软组织对比度

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

第八章核子医学设备市场：依技术

• 混合成像
  • PET/CT系统
  • SPECT/CT系统
• 正子断层扫描
• 单光子发射电脑断层扫描

第九章核医设备市场（依产品类型）

• 诊断设备
• 治疗设备和放射性药物

第 10 章核医设备市场：按应用

• 心臟病学
• 神经病学
• 肿瘤学

第 11 章 核医设备市场（依最终使用者）

• 诊断影像中心
• 医院
• 研究所

第 12 章：美洲核子医学设备市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

第 13 章：欧洲、中东和非洲的核子医学设备市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

第14章：亚太核医学设备市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十五章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • AMETEK Inc.
  • BJ Madan & Co
  • Berthold Technologies GmbH & Co.KG
  • Blue Earth Diagnostics
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health
  • COMECER SpA
  • Digirad
  • Exosens
  • GE Healthcare
  • Geebee International
  • Hidex Oy
  • Jubilant DraxImage, Inc.
  • Koninklijke Philips NV
  • Mirion Technologies, Inc.
  • Neusoft Medical Systems Co., Ltd.
  • Nucleonix Systems（P）Ltd.
  • Nucleuz Healthcare Pvt Ltd
  • NUVIATech Healthcare
  • OVIS Imaging Solutions
  • Radiation Monitoring Devices
  • Rotem Industries Ltd.
  • Siemens Healthineers AG
  • Spectrum Instrumentation

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

The Nuclear Medicine Instrumentation Market was valued at USD 4.23 billion in 2024 and is projected to grow to USD 4.51 billion in 2025, with a CAGR of 6.76%, reaching USD 6.27 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 4.23 billion
Estimated Year [2025]	USD 4.51 billion
Forecast Year [2030]	USD 6.27 billion
CAGR (%)	6.76%

A Comprehensive Exploration of Nuclear Medicine Instrumentation Shaping Diagnostic and Therapeutic Innovations in Healthcare Delivery Worldwide

Over the past decade, nuclear medicine instrumentation has increasingly become a linchpin in personalized diagnostic and therapeutic pathways, revolutionizing how clinicians detect and treat complex diseases. As healthcare providers strive to enhance precision and patient outcomes, advanced imaging modalities and targeted radiopharmaceutical delivery systems have emerged at the forefront of medical innovation. This transformation has been driven by breakthroughs in detector sensitivity, image reconstruction algorithms, and the convergence of imaging with therapeutic functions. Consequently, nuclear medicine now occupies a pivotal position within multidisciplinary care paradigms, offering unparalleled insights into physiological processes at the molecular level.

Transitioning from conventional gamma cameras to sophisticated hybrid platforms, the field has undergone a profound metamorphosis. Hybrid imaging systems that combine positron emission tomography with computed tomography or single photon emission computed tomography with CT have enabled seamless integration of anatomical and functional data. These developments have not only sharpened diagnostic confidence but also expanded the scope of applications across cardiology, neurology, and oncology. Moreover, the ongoing miniaturization of components, along with enhancements in data processing and radiopharmaceutical chemistry, continues to lower operational barriers, facilitating broader adoption across hospitals, diagnostic centers, and research institutions. This report embarks on a comprehensive exploration of these technological advances, regulatory evolutions, and market dynamics, laying a solid foundation for the in-depth analysis that follows.

Unveiling the Paradigm Shifts Driving Next Generation Nuclear Medicine Instrumentation Through Integration of AI Analytics Theranostics and Precision Imaging

The landscape of nuclear medicine instrumentation has been reshaped by converging trends that are redefining clinical workflows and research frontiers. Foremost among these is the integration of artificial intelligence and machine learning into image acquisition and interpretation. By automating image segmentation and quantifying tracer uptake with unprecedented precision, these algorithms are streamlining decision-making and alleviating radiologist workloads. Simultaneously, the surge in theranostic approaches-where molecular imaging agents double as therapeutic vehicles-has introduced a new dimension of personalized medicine. Targeted radionuclide therapies are now guided in real time by diagnostic feedback loops, ensuring higher efficacy and minimizing off-target effects.

Additionally, the emphasis on hybrid imaging systems has fostered cross-disciplinary collaborations, uniting experts in radiopharmaceutical chemistry, nuclear physics, and bioengineering. This collective effort has given rise to next-generation detectors utilizing novel scintillating materials and semiconductor technology, thereby elevating spatial resolution and sensitivity. The growing need for point-of-care diagnostics has also spurred the development of compact, portable SPECT/CT and PET/CT systems, facilitating decentralized clinical trials and improving access in remote or community-based settings. Collectively, these transformative shifts underscore a trajectory toward faster, smarter, and more patient-centric nuclear medicine practices.

Assessing the Ripple Effects of United States Tariffs on Nuclear Medicine Instrumentation Supply Chains Manufacturing Costs and Global Collaboration

In 2025, newly enacted United States tariff policies have generated multifaceted ripple effects across the nuclear medicine instrumentation ecosystem. Heightened duties on imported detectors, CT modules, and specialized components have compelled manufacturers to reassess global supply chain architectures. In response, leading original equipment manufacturers are diversifying their sourcing strategies and accelerating investments in local assembly and component fabrication. While these adjustments aim to offset increased import costs, they also introduce complexities in quality control and regulatory compliance, given the stringent safety standards governing radioactive materials and imaging devices.

Consequently, distributors and end users are recalibrating procurement plans to accommodate extended lead times and restructured pricing models. Some institutions have turned to consortia agreements to leverage collective purchasing power and negotiate more favorable terms with suppliers. At the same time, research partners are exploring alternative detector chemistries and modular designs that can be adapted to regional manufacturing capabilities. Through these adaptive measures, stakeholders are striving to maintain uninterrupted clinical operations and uphold high standards of patient care. This section examines how the tariff environment is catalyzing innovation in production processes, spurring supply chain resilience, and redefining international collaboration within the nuclear medicine sector.

Strategic Insights Emerging from Comprehensive Technology Product Category Application and End User Segmentation in Nuclear Medicine Instrumentation Markets

Insights drawn from technology adoption, product category differentiation, clinical application, and end-user specialization reveal the intricate drivers shaping today's nuclear medicine market. The evolution of hybrid imaging platforms, including PET/CT and SPECT/CT modalities, underscores a shift toward systems that seamlessly integrate functional and anatomical data, satisfying the exacting requirements of oncological staging and neurological assessment. Simultaneously, the delineation between diagnostic instruments and therapeutic instruments coupled with radiopharmaceuticals highlights a dual-track strategy: one focused on image acquisition and interpretation, the other on delivering targeted radioligands for treatment.

Clinical fields such as cardiology, neurology, and oncology are each benefitting uniquely from these advancements, with oncology driving the largest volume of tracer development and neurology increasingly leveraging imaging biomarkers for neurodegenerative conditions. Moreover, the dispersal of capabilities across diagnostic imaging centers, hospitals, and research institutions reflects a broadening user base that demands scalable solutions. Diagnostic imaging centers prioritize throughput and cost efficiency, while hospitals emphasize integrated workflows within electronic health record systems. Meanwhile, research institutes underpin innovation pipelines, validating novel radiotracers and pilot-testing miniaturized instrumentation. These layered insights inform strategic positioning and product development roadmaps for stakeholders operating across the full spectrum of nuclear medicine instrumentation.

Understanding Regional Dynamics in the Americas Europe Middle East Africa and Asia Pacific to Uncover Growth Drivers and Adoption Patterns in Nuclear Imaging

Regional dynamics are driving divergent adoption rates and innovation trajectories across the Americas, Europe Middle East Africa region, and the Asia Pacific. In the Americas, established healthcare infrastructures and substantial research funding continue to foster early adoption of advanced PET/CT and theranostic platforms. North American centers are increasingly deploying integrated imaging therapies at scale, while Latin American markets demonstrate growing interest in portable SPECT/CT solutions to expand diagnostic access beyond urban hubs.

Across Europe, Middle East, and Africa, regulatory harmonization efforts and pan-regional research collaborations are enabling cross-border clinical trials and enhanced data sharing. Western European nations maintain leadership in radiopharmaceutical development, whereas emerging markets in the Gulf cooperation council countries and Southern Africa are investing in modernizing nuclear infrastructure. Meanwhile, the Asia Pacific region is characterized by rapid expansion driven by rising noncommunicable disease prevalence and robust government initiatives. Countries such as China, Japan, and India are scaling up local manufacturing capabilities and forging strategic alliances with global technology providers. These regional contrasts provide invaluable guidance for tailoring market entry approaches and aligning stakeholder investments with localized healthcare priorities.

Revealing Competitive Leadership and Collaborative Innovation Strategies Adopted by Key Global Participants in Nuclear Medicine Instrumentation

Leading participants in the nuclear medicine instrumentation sector are adopting multifaceted strategies to maintain competitive advantage and stimulate technology diffusion. Major global corporations continue to expand their product portfolios through targeted acquisitions and strategic research partnerships, embedding advanced detector technologies and AI-powered software into existing platforms. Concurrently, mid-sized regional players are carving out specialized niches by focusing on cost-effective modular systems and localized service models that cater to emerging markets.

Innovation alliances between imaging equipment manufacturers and radiopharmaceutical developers are accelerating integrated theranostic solutions, enabling coordinated roll-outs of diagnostic agents and companion therapies. Furthermore, joint ventures with academic institutions are enhancing R&D pipelines, particularly in developing novel tracers for neuroinflammation and receptor-targeted oncology. By balancing broad geographic reach with deep domain expertise, these organizations are cultivating resilient supply chains, reinforcing after-sales support networks, and driving sustained customer loyalty. The synthesis of these competitive and collaborative initiatives shapes a dynamic landscape where continuous innovation and partnership agility are paramount.

Formulating Practical Roadmaps for Industry Leaders to Optimize Technology Investments Forge Strategic Partnerships and Enhance Patient Outcomes

To harness the opportunities presented by technological convergence and regulatory evolution, industry leaders should prioritize strategic investments in modular, scalable platforms that accommodate both diagnostic imaging and therapeutic applications. By adopting flexible manufacturing frameworks, organizations can mitigate supply chain disruptions while accelerating deployment of next-generation detectors and radiopharmaceuticals. Establishing cross-functional teams that include regulatory affairs, clinical specialists, and data scientists can further streamline product approval timelines and enhance market responsiveness.

Collaboration with academic research centers and contract development organizations will be essential for fast-tracking the discovery and validation of novel tracers. Equally important is the cultivation of a comprehensive digital ecosystem, integrating advanced analytics and cloud-based image management to support remote interpretations and decentralized clinical trials. Building robust training programs for technologists and clinicians will drive effective technology utilization and foster stakeholder confidence. Ultimately, aligning these initiatives with patient-centered value propositions and health economic models will ensure that investments translate into measurable clinical benefits and sustainable growth trajectories.

Detailing Rigorous Mixed Methodology Combining Primary Engagement Secondary Research and Advanced Analytical Techniques to Ensure Data Integrity and Reliability

This research employs a mixed-methodology framework, combining extensive primary engagements with clinicians, imaging specialists, and procurement executives with rigorous secondary research across peer-reviewed journals, regulatory databases, and patent filings. Primary interviews and surveys yield firsthand qualitative insights into clinical workflows, purchasing criteria, and emerging needs, while secondary data sources provide contextual validation and trend analysis. Triangulation of these inputs ensures robustness, with cross-verification workshops conducted to reconcile divergent perspectives and refine key assumptions.

Quantitative analysis includes benchmarking component lifecycles, pricing variances, and throughput metrics, supported by statistical modeling to identify correlation patterns and technology adoption curves. A systematic review of regulatory pathways and reimbursement policies informs the risk assessment of market entry scenarios. Finally, iterative expert validation sessions with academic and industry advisory panels serve to stress-test the findings and calibrate strategic recommendations. This methodological rigor guarantees that the conclusions drawn are both actionable and reflective of real-world dynamics in the nuclear medicine instrumentation landscape.

Synthesizing Key Findings into Forward Looking Perspective Guiding Stakeholders on Emerging Trends Opportunities and Strategic Imperatives in Nuclear Medicine

This comprehensive assessment has illuminated the critical technological innovations, regulatory factors, and competitive dynamics that are defining the future of nuclear medicine instrumentation. From the ascendancy of hybrid imaging systems and AI-driven analytics to the emergence of theranostic paradigms, stakeholders are positioned to unlock significant clinical and operational value. Tariff-induced supply chain adaptations and regional differentiation further underscore the necessity for agile strategic planning and robust partnership ecosystems.

Looking ahead, the convergence of digital health platforms, precision radiopharmaceuticals, and decentralized diagnostic capabilities will continue to drive differentiation. Organizations that integrate cross-disciplinary expertise, prioritize patient-centric workflows, and commit to ongoing innovation will lead the next wave of growth. By synthesizing the insights presented herein, decision makers can confidently navigate emerging challenges, seize value creation opportunities, and advance the standard of care in nuclear medicine.

In summary, the trajectory of nuclear medicine instrumentation is characterized by rapid evolution and multifaceted opportunity. The strategic imperatives outlined in this report offer a clear roadmap for stakeholders seeking to translate cutting-edge science into tangible healthcare impact.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Integration of artificial intelligence and machine learning for enhanced PET scanner image reconstruction accuracy and speed
• 5.2. Development of cyclotron-free radioisotope production to decentralize access to PET tracers in regional healthcare facilities
• 5.3. Advancements in solid-state photodetectors improving time-of-flight resolution in next-generation SPECT systems
• 5.4. Emergence of theranostic instrumentation combining targeted radionuclide therapy and diagnostic imaging in oncology
• 5.5. Implementation of digital twin simulations to optimize workflow and maintenance schedules for nuclear medicine equipment
• 5.6. Integration of cloud-based data management for multimodal nuclear imaging studies enabling real-time remote interpretation
• 5.7. Miniaturized portable gamma cameras facilitating point-of-care myocardial perfusion imaging in emergency settings
• 5.8. Adoption of hybrid PET/MRI systems with ultra-high field strength magnets for improved soft tissue contrast in brain imaging

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Nuclear Medicine Instrumentation Market, by Technology

• 8.1. Introduction
• 8.2. Hybrid Imaging
  • 8.2.1. PET/CT Systems
  • 8.2.2. SPECT/CT Systems
• 8.3. Positron Emission Tomography
• 8.4. Single Photon Emission Computed Tomography

9. Nuclear Medicine Instrumentation Market, by Product Category

• 9.1. Introduction
• 9.2. Diagnostic Instruments
• 9.3. Therapeutic Instruments & Radiopharmaceuticals

10. Nuclear Medicine Instrumentation Market, by Application

• 10.1. Introduction
• 10.2. Cardiology
• 10.3. Neurology
• 10.4. Oncology

11. Nuclear Medicine Instrumentation Market, by End User

• 11.1. Introduction
• 11.2. Diagnostic Imaging Centers
• 11.3. Hospitals
• 11.4. Research Institutes

12. Americas Nuclear Medicine Instrumentation Market

• 12.1. Introduction
• 12.2. United States
• 12.3. Canada
• 12.4. Mexico
• 12.5. Brazil
• 12.6. Argentina

13. Europe, Middle East & Africa Nuclear Medicine Instrumentation Market

• 13.1. Introduction
• 13.2. United Kingdom
• 13.3. Germany
• 13.4. France
• 13.5. Russia
• 13.6. Italy
• 13.7. Spain
• 13.8. United Arab Emirates
• 13.9. Saudi Arabia
• 13.10. South Africa
• 13.11. Denmark
• 13.12. Netherlands
• 13.13. Qatar
• 13.14. Finland
• 13.15. Sweden
• 13.16. Nigeria
• 13.17. Egypt
• 13.18. Turkey
• 13.19. Israel
• 13.20. Norway
• 13.21. Poland
• 13.22. Switzerland

14. Asia-Pacific Nuclear Medicine Instrumentation Market

• 14.1. Introduction
• 14.2. China
• 14.3. India
• 14.4. Japan
• 14.5. Australia
• 14.6. South Korea
• 14.7. Indonesia
• 14.8. Thailand
• 14.9. Philippines
• 14.10. Malaysia
• 14.11. Singapore
• 14.12. Vietnam
• 14.13. Taiwan

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. AMETEK Inc.
  • 15.3.2. B J Madan & Co
  • 15.3.3. Berthold Technologies GmbH & Co.KG
  • 15.3.4. Blue Earth Diagnostics
  • 15.3.5. Bruker Corporation
  • 15.3.6. Canon Medical Systems Corporation
  • 15.3.7. Cardinal Health
  • 15.3.8. COMECER SpA
  • 15.3.9. Digirad
  • 15.3.10. Exosens
  • 15.3.11. GE Healthcare
  • 15.3.12. Geebee International
  • 15.3.13. Hidex Oy
  • 15.3.14. Jubilant DraxImage, Inc.
  • 15.3.15. Koninklijke Philips N.V.
  • 15.3.16. Mirion Technologies, Inc.
  • 15.3.17. Neusoft Medical Systems Co., Ltd.
  • 15.3.18. Nucleonix Systems (P) Ltd.
  • 15.3.19. Nucleuz Healthcare Pvt Ltd
  • 15.3.20. NUVIATech Healthcare
  • 15.3.21. OVIS Imaging Solutions
  • 15.3.22. Radiation Monitoring Devices
  • 15.3.23. Rotem Industries Ltd.
  • 15.3.24. Siemens Healthineers AG
  • 15.3.25. Spectrum Instrumentation

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

• FIGURE 1. NUCLEAR MEDICINE INSTRUMENTATION MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 14. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 16. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. NUCLEAR MEDICINE INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 22. NUCLEAR MEDICINE INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 23. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHAI
• FIGURE 24. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHSTATISTICS
• FIGURE 25. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHCONTACTS
• FIGURE 26. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. NUCLEAR MEDICINE INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PET/CT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PET/CT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SPECT/CT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SPECT/CT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY THERAPEUTIC INSTRUMENTS & RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY THERAPEUTIC INSTRUMENTS & RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 46. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 47. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 48. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 49. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 50. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 51. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 52. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 53. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 54. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 55. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 56. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 57. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 58. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 59. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 60. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 61. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 62. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 63. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 64. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 65. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 66. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 67. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 68. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 69. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 70. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 71. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 72. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 73. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 74. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 75. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 76. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 77. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 78. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 79. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 80. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 81. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 82. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 83. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 84. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 85. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 86. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 87. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 88. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 89. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 90. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 91. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 92. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 93. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 94. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 95. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 96. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 97. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 98. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 99. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 100. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 101. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 102. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 103. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 104. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 105. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 106. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 107. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 108. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 117. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 118. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 119. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 121. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 122. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 123. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 124. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 125. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 126. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 127. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 128. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 129. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 130. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 131. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 132. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 133. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 134. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 135. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 136. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 137. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 138. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 139. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 140. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 141. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 142. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 143. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 144. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 145. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 146. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 147. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 148. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 149. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 150. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 151. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 152. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 153. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 154. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 155. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 156. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 157. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 158. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 159. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 160. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 161. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 162. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 163. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 164. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 165. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 166. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 167. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 168. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 169. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 170. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 171. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 172. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 173. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 174. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 175. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 176. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 177. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 178. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 179. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 180. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 191. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 192. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 194. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 196. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 198. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 200. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 202. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 204. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 206. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 208. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 210. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 211. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 212. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 213. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 214. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 215. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 216. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 217. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 218. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 219. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 220. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 221. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 222. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 223. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 224. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 225. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 226. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 227. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 228. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 229. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 230. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 231. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 232. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 233. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 234. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 235. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 236. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 237. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 238. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 239. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 240. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 241. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 242. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 243. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 244. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 245. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 246. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 247. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 248. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 249. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 250. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 251. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 252. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 253. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 254. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 255. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 256. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 257. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 258. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 259. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 261. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 262. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 263. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 264. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 265. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 266. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 267. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 268. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 269. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 270. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 271. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 272. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 273. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 274. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 275. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 276. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 277. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 278. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 279. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 280. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 281. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 282. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 283. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 284. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 285. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 286. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 287. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 288. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 289. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 290. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 291. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 292. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 293. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
• TABLE 294. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
• TABLE 295. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
• TABLE 296. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
• TABLE 297. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 298. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 299. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 300. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 301. NORWAY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 302. NORWAY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
• TABLE 303. NORWAY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (U